Svelte Medical Systems

675 Central Avenue, New Providence, NJ 07974

Private
Healthcare & Pharmaceuticals - Medical Devices
around $2.5 - 5M
around 20 - 50
(908) 264-2194
908-728-9981


Svelte Medical Systems is located at 675 Central Avenue, New Providence, NJ 07974. It has around 20 - 50 employees. Its revenue is around $2.5 - 5M. Svelte Medical Systems, Inc. (Svelte) was founded in 2007 with a mission to address key clinical issues in the cardiovascular stent market by improving stent deliverability, reducing procedural costs and improving safety. To achieve these significant benefits to the physician, patient and healthcare system Svelte has developed the lowest profile and most deliverable balloon expandable stent in the market, along with technology to create a non-inflammatory Drug Eluting Stent (DES). The company ...

Brand Quality - 1/2
Do you believe in Svelte Medical Systems's mission?


Result Not Found.

10 Contacts at this company
Keith Roberts
Vice President of Operations
Mark Kielek
VP Quality Assurance
Richard Dakers
Member of the Board
Jennifer Lemond
Chief Financial Officer
Astrid Verkaik
European Sales Director
Job Huiskamp
Therapy Manager Coronary
Jack Darby
President & CEO
Cory Zegel
R&D Senior Engineer
Margaret Kelleher
R&D Engineer I

Jan 10, 2018 17:30:36
NEW PROVIDENCE, N.J.--(BUSINESS WIRE)--The Christ Hospital, Lindner Research Center in Cincinnati, Ohio, enrolled the first patient in Svelte Medical System’s OPTIMIZE clinical  [...]

Jan 10, 2018 17:07:00
NEW PROVIDENCE, N.J.--(BUSINESS WIRE)--The Christ Hospital, Lindner Research Center in Cincinnati, Ohio, enrolled the first patient in Svelte Medical System’s OPTIMIZE clinical  [...]

May 16, 2017 17:30:38
PARIS--(BUSINESS WIRE)--Final 5-year outcomes from the DIRECT first-in-man study were presented at the EuroPCR symposium today, with 0% clinically-driven Target Lesion  [...]

Oct 31, 2016 17:49:11
NEW PROVIDENCE, N.J.--(BUSINESS WIRE)--Svelte Medical Systems, Inc. today announced the start of enrollment in the DIRECT III post-market registry study. DIRECT III is an [...]

Oct 31, 2016 17:30:27
NEW PROVIDENCE, N.J.--(BUSINESS WIRE)--Svelte Medical Systems, Inc. today announced the start of enrollment in the DIRECT III post-market registry study. DIRECT III is an [...]

Get Started Today : Sign up in 20 seconds
Search with 20+ criteria.
Export results in seconds.
Bad emails?
No worry, we give two extras for every bad email.